J&
Johnson & Johnson Innovation
Corporate VCActiveJohnson & Johnson Innovation collaboratea with innovators to incorporate science into healthcare solutions.
56
Investments
8
Exits
—
AUM
14.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Johnson & Johnson Innovation.
Investment Thesis & Strategy
Johnson & Johnson Innovation, as a corporate venture capital arm, invests across various stages in healthcare companies, seeking to integrate innovative science into healthcare solutions.
Investment Activity
Deals per year over the last 13 years
2
20110
20120
20130
20142
20151
20160
20170
20183
20190
20201
20210
20221
2023Portfolio Companies
Selected investments from their portfolio of 56 companies
V
Vivani Medical
Biotech · Growth, 2023
C
Cellarity
Biotech · Series B, 2021
B
BenevolentAI
AI/ML · Series C+, 2019
X
X-Therapeutics
Biotech · Series A, 2019
A
Avidity Biosciences
Biotech · Series B, 2019
S
Surface Oncology
Biotech · Series B, 2016
A
Achillion Pharmaceuticals
Biotech · Series C+, 2015
P
Protagonist Therapeutics
Biotech · Series B, 2015
E
Epizyme
Biotech · Series B, 2011
A
Alvine Therapeutics
Biotech · Series A, 2011
Frequently Asked Questions
Johnson & Johnson Innovation focuses on Series A, Series B stage investments.